Key result
In silico analysis identifies 8 rare deleterious GHSR variants potentially linked to obesity.
Why the study?
Allelic variants of the GHSR gene can alter signaling and hormone-binding phenotypes; identifying these variants can aid in understanding obesity pathophysiology and defining strategies for diagnosis or treatment.
In silico analysis identified 8 rare missense variants in the GHSR gene that are predicted to be deleterious and may be linked to the pathophysiology of obesity.
GHSR variants may shape body composition phenotypes; leaves open causal role and therapeutic targeting in obesity.
Background/Objectives: In recent years, efforts to understand obesity’s pathophysiology have focused on satiety signals in the hypothalamus and hormonal signalling in orexigenic and anorexigenic neurons. These signals, linked to hunger, satiety, and energy expenditure, are influenced by peptides that activate or suppress specific pathways. However, different phenotypes related to body composition result from mutations (allelic variants) in genes that encode these proteins, particularly peptide receptors. Specifically, the hormone receptor ghrelin (GHSR), located on the surface of orexigenic neurons, has been linked to the regulation of hunger. Additionally, the production and secretion of ghrelin, a peptide hormone produced by the stomach, may exhibit varying sensitivity in its receptor based on an individual’s nutritional status. Moreover, allelic variants of the GHSR gene may potentially lead to significant alterations in signalling provided by the GHSR receptor, resulting in modified hormone-binding phenotypes. In this context, the search for allelic variants that can account for diverse phenotypes, whether thinness or overweight/obesity, can aid in comprehending the pathway and defining new strategies for early laboratory diagnosis or target peptides for treatment. Methods: Initial mining produced 373 non-random SNPs located in missense regions. A total of 373 missense variants were initially identified in the GHSR gene. After applying a global minor allele frequency (MAF) filter of <1%, 20 rare missense variants remained. Results: These variants were subsequently analyzed using nine in silico pathogenicity prediction tools, resulting in the prioritization of eight variants predicted as deleterious by at least four algorithms. These variants were further analysed using the HOPE project web server and the SwissModel database. Conclusions: Through these analyses and future investigations into these mutations, we may gain a more comprehensive understanding of the implications of these mutations and their potential correlation with the pathophysiology of obesity.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2026) studied Obesity. Missense variants in the GHSR gene was evaluated on Pathogenicity prediction. In silico analysis of 373 missense variants in the GHSR gene prioritized 8 rare variants predicted as deleterious by at least four algorithms, suggesting a potential role in obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: